IPSEN Claimed Company

At Ipsen, we are committed to improving patients’ lives. With over 90 years of experience, we focus our energy on developing and commercializing new therapeutic options in oncology, neuroscience, and rare diseases. The patients we serve live with serious and rare diseases, and our end goal is to ensure that we provide innovative medicines to help address unmet patient needs as quickly as possible. It’s this approach to our work that drives Ipsen’s ambition of launching at least one new product or meaningful indication each year. Every day, we empower our nearly 6,000 colleagues across the globe to help make a difference in the lives of patients – join us. read more

EMPLOYEE PARTICIPANTS: 82

TOTAL RATINGS: 521

CEO: David Loew

HR or Marketing? Claim Your Free Employer Account

David Loew IPSEN CEO Rating

IPSEN's CEO, David Loew, has 51 employee ratings and a score of 73/100, placing them in the Top 20% of similar size companies on Comparably with 5,001-10,000 Employees and Top 35% of other companies in Boston.

Last updated 10 days ago.

Where This Score Ranks IPSEN's CEO Rating

TOP
20%
In the Top 20% of 1808 Similar Sized Companies on Comparably
TOP
35%
In the Top 35% of 270 Nearby Companies in Boston
2nd
2nd place versus 4 competitors rated on Comparably

Nov

Apr

Jul

Sep

Jan

B+73 / 100

Jan

IPSEN CEO David Loew Bio

David has over 25 years of experience in the pharmaceutical industry where he has held various global executive positions in major pharmaceutical and biotechnology companies. Prior to joining Ipsen David was Executive Vice-President and President of the oncology division of Baxalta.

David started his biopharma career at Johnson & Johnson and Janssen Pharmaceutica (1989-2004) where he held a variety of senior US sales and marketing positions across therapeutic areas in primary care, specialty care, and oncology.

He then joined Novartis (2005-2012), where he successively served as the global business franchise head for the company’s respiratory and dermatology franchise in Basel, Switzerland; President and Chief Executive Officer of the pharmaceutical division in Canada; and the head of oncology for Northern, Central and Eastern Europe. From 2012 to 2014, he served as Chief Commercial Officer of Endocyte, an oncology biotechnology company.

Prior to his biopharma career David was an officer in the United States Army. He is a graduate of the University of Cincinnati.

David serves on the Boards of uniQure, PhRMA, EFPIA and Camping and Education Foundation.

Who Ranks IPSEN's CEO Rating the Highest?

Ethnicity - Caucasian 96/100

Experience - Over 10 Years 90/100

Gender - Male 90/100

Who Ranks IPSEN's CEO Rating the Lowest?

Not Enough Ratings To Show Who Ranks CEO Rating the Lowest

Anonymously rate my experience at IPSEN

IPSEN CEO David Loew At a Glance

The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at IPSEN.

Based on 51 ratings, David Loew ranks right below bioMerieux's CEO, Alexandre Merieux.

IPSEN's CEO is highly regarded by Caucasian employees, employees with Over 10 Years experience, and Male employees. Overall, the CEO score has remained stable over the last 90 days.